In particular, we have shown that there is an increase in the concentration of Trp in saliva with a negative status of progesterone receptors and high expression values of the proliferation marker Ki-67, which apparently determines high concentrations of Trp in the subgroup of luminal B HER2-negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.